These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26378448)

  • 1. Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome.
    Shinchi H; Yuki N; Ishida H; Hirata K; Wakao M; Suda Y
    PLoS One; 2015; 10(9):e0137966. PubMed ID: 26378448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome.
    Cats EA; van der Pol WL; Tio-Gillen AP; Diekstra FP; van den Berg LH; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):502-4. PubMed ID: 25157033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome.
    Lardone RD; Yuki N; Irazoqui FJ; Nores GA
    Sci Rep; 2016 Jan; 6():19901. PubMed ID: 26818965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
    Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
    Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
    Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
    J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome.
    Bonyadi MR; Barzegar M; Badalzadeh R; Hashemilar M
    Iran J Immunol; 2010 Jun; 7(2):117-23. PubMed ID: 20574125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.
    Kuijf ML; van Doorn PA; Tio-Gillen AP; Geleijns K; Ang CW; Hooijkaas H; Hop WC; Jacobs BC
    J Neurol Sci; 2005 Dec; 239(1):37-44. PubMed ID: 16154154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
    Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
    Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies.
    Lardone RD; Alaniz ME; Irazoqui FJ; Nores GA
    J Neuroimmunol; 2006 Apr; 173(1-2):174-9. PubMed ID: 16376437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcal IdeS: therapeutic potential for Guillain-Barré syndrome.
    Takahashi R; Yuki N
    Sci Rep; 2015 Jul; 5():10809. PubMed ID: 26194472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GM1 IgG antibodies in Guillain-Barré syndrome: fine specificity is associated with disease severity.
    Lardone RD; Yuki N; Odaka M; Daniotti JL; Irazoqui FJ; Nores GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):629-33. PubMed ID: 19965859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antibodies in neuropathy patients by synthetic GM1 mimics.
    Pukin AV; Jacobs BC; Tio-Gillen AP; Gilbert M; Endtz HP; van Belkum A; Visser GM; Zuilhof H
    Glycobiology; 2011 Dec; 21(12):1642-50. PubMed ID: 21798866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of axonal Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ganglioside antibodies in Guillain-Barré syndrome; useful diagnostic markers as well as possible pathogenetic factors.
    Kusunoki S
    Intern Med; 2003 Jun; 42(6):457-8. PubMed ID: 12857038
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.